Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 778 items for :

  • "long-term" x
Clear All
Nelma Veronica Marques Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed Close
,
Luiz Eduardo Armondi Wildemberg Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed Close
, and
Monica R Gadelha Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Monica R Gadelha in
Google Scholar
PubMed Close

normalising insulin-like growth factor 1 (IGF1) levels that are inadequately controlled by octreotide or lanreotide ( 2 ). Long-term outcomes from clinical studies have demonstrated effective and consistent biochemical control with pasireotide for up to 304

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0155
Volume/Issue:
Volume 12: Issue 10
Open access
María Dolores Rodríguez Arnao Pediatric Endocrinology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other papers by María Dolores Rodríguez Arnao in
Google Scholar
PubMed Close
,
Amparo Rodríguez Sánchez Pediatric Endocrinology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other papers by Amparo Rodríguez Sánchez in
Google Scholar
PubMed Close
,
Ignacio Díez López Hospital Universitario Araba, Araba/Alava, Spain

Search for other papers by Ignacio Díez López in
Google Scholar
PubMed Close
,
Joaquín Ramírez Fernández Hospital Universitario Príncipe de Asturias, Oviedo, Spain

Search for other papers by Joaquín Ramírez Fernández in
Google Scholar
PubMed Close
,
Jose Antonio Bermúdez de la Vega Centro Nuevas Tecnologias, Sevilla, Spain

Search for other papers by Jose Antonio Bermúdez de la Vega in
Google Scholar
PubMed Close
,
Diego Yeste Fernández Hospital Vall d’Hebrón, Barcelona, Spain

Search for other papers by Diego Yeste Fernández in
Google Scholar
PubMed Close
,
María Chueca Guindulain Complejo Hospitalario de Navarra, Pamplona, Spain

Search for other papers by María Chueca Guindulain in
Google Scholar
PubMed Close
,
Raquel Corripio Collado Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

Search for other papers by Raquel Corripio Collado in
Google Scholar
PubMed Close
,
Jacobo Pérez Sánchez Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain

Search for other papers by Jacobo Pérez Sánchez in
Google Scholar
PubMed Close
,
Ana Fernández González Merck S.L.U., Madrid, Spain

Search for other papers by Ana Fernández González in
Google Scholar
PubMed Close
, and
ECOS Spain Study Collaborative Investigator Group
Search for other papers by ECOS Spain Study Collaborative Investigator Group in
Google Scholar
PubMed Close

-hGH treatment with easypod™, gender, indication, person who performed injections, treatment duration and height SDS before start of GH treatment, were consistent with those selected in prediction models for long-term growth responses ( 36 ). Besides this, in the

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0325
Volume/Issue:
Volume 8: Issue 9
Open access
Lauren E Henke Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA

Search for other papers by Lauren E Henke in
Google Scholar
PubMed Close
,
John D Pfeifer Department of Pathology, Washington University School of Medicine, St. Louis, Missouri, USA

Search for other papers by John D Pfeifer in
Google Scholar
PubMed Close
,
Thomas J Baranski Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Thomas J Baranski in
Google Scholar
PubMed Close
,
Todd DeWees Division of Biomedical Statistics and Informatics, Mayo Clinic, Scottsdale, Arizona, USA

Search for other papers by Todd DeWees in
Google Scholar
PubMed Close
, and
Perry W Grigsby Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA
Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Perry W Grigsby in
Google Scholar
PubMed Close

pathologic markers, such as histologic subtype or somatic mutation profile, which might stratify patients at risk for these poor long-term outcomes. The majority of PTC cases comprise two histologic subtypes: classic papillary (CP) and follicular variant

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0264
Volume/Issue:
Volume 7: Issue 12
Open access
Annelies van’t Westeinde Department of Women’s and Children’s Health, Karolinska Institutet and Division of Pediatrics, Unit for Pediatric Endocrinology and Metabolic Disorders, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Annelies van’t Westeinde in
Google Scholar
PubMed Close
,
Leif Karlsson Department of Women’s and Children’s Health, Karolinska Institutet and Division of Pediatrics, Unit for Pediatric Endocrinology and Metabolic Disorders, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Leif Karlsson in
Google Scholar
PubMed Close
,
Valeria Messina Department of Women’s and Children’s Health, Karolinska Institutet and Division of Pediatrics, Unit for Pediatric Endocrinology and Metabolic Disorders, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Valeria Messina in
Google Scholar
PubMed Close
,
Lena Wallensteen Department of Women’s and Children’s Health, Karolinska Institutet and Division of Pediatrics, Unit for Pediatric Endocrinology and Metabolic Disorders, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Lena Wallensteen in
Google Scholar
PubMed Close
,
Manuela Brösamle European Patient Advocacy Group for Adrenal Diseases, European Reference Network on Rare Endocrine Conditions (Endo ERN), Endo ERN Coordinating Centre, Leiden, The Netherlands

Search for other papers by Manuela Brösamle in
Google Scholar
PubMed Close
,
Giorgio Dal Maso ArfSAG (Associazione Refionale Famiglie Sindrome Adreno Genitale) c/o Unita Operativa di Pediatria, Azienda Ospedaliero Universitaria di Bologna, Policlinico S Orsala-Malpighi, Bologna, Italy

Search for other papers by Giorgio Dal Maso in
Google Scholar
PubMed Close
,
Alessandro Lazzerini Spanish Association of Congenital Adrenal Hyperplasia (CAH), Spain

Search for other papers by Alessandro Lazzerini in
Google Scholar
PubMed Close
,
Jette Kristensen ePAG & Chair of Danish Addison Patient Association, Aarhus, Denmark

Search for other papers by Jette Kristensen in
Google Scholar
PubMed Close
,
Diana Kwast Dutch Adrenal Society NVACP, Nijkerk, The Netherlands

Search for other papers by Diana Kwast in
Google Scholar
PubMed Close
,
Lea Tschaidse Department of Endocrinology, Medizinische Klinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Lea Tschaidse in
Google Scholar
PubMed Close
,
Matthias K Auer Department of Endocrinology, Medizinische Klinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Matthias K Auer in
Google Scholar
PubMed Close
,
Hanna F Nowotny Department of Endocrinology, Medizinische Klinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Hanna F Nowotny in
Google Scholar
PubMed Close
,
Luca Persani Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy

Search for other papers by Luca Persani in
Google Scholar
PubMed Close
,
Nicole Reisch Department of Endocrinology, Medizinische Klinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Nicole Reisch in
Google Scholar
PubMed Close
, and
Svetlana Lajic Department of Women’s and Children’s Health, Karolinska Institutet and Division of Pediatrics, Unit for Pediatric Endocrinology and Metabolic Disorders, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by Svetlana Lajic in
Google Scholar
PubMed Close

interventions are sub-optimal and in addition entail a procedure for a non-life-threatening condition performed without the patient being able to give consent. Though short-term surgical complications may be fixed ( 13 , 16 , 17 ), long-term negative effects

Article Type:
Review Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-22-0400
Volume/Issue:
Volume 12: Issue 4
Open access
Julia Modesto Vicente Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Julia Modesto Vicente in
Google Scholar
PubMed Close
,
Junia Carolina Santos-Silva Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Junia Carolina Santos-Silva in
Google Scholar
PubMed Close
,
Caio Jordão Teixeira Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Caio Jordão Teixeira in
Google Scholar
PubMed Close
,
Dailson Nogueira de Souza Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Dailson Nogueira de Souza in
Google Scholar
PubMed Close
,
Jean Franciesco Vettorazzi Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, Campinas, Brazil

Search for other papers by Jean Franciesco Vettorazzi in
Google Scholar
PubMed Close
,
Fabiola Sales Furtuoso Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Fabiola Sales Furtuoso in
Google Scholar
PubMed Close
,
Isabel Gouveia Adabo Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Isabel Gouveia Adabo in
Google Scholar
PubMed Close
,
Fabio Takeo Sato Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, State University of Campinas, Campinas, Brazil

Search for other papers by Fabio Takeo Sato in
Google Scholar
PubMed Close
,
Marco Aurélio Ramirez Vinolo Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, State University of Campinas, Campinas, Brazil

Search for other papers by Marco Aurélio Ramirez Vinolo in
Google Scholar
PubMed Close
,
Everardo Magalhães Carneiro Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, Campinas, Brazil

Search for other papers by Everardo Magalhães Carneiro in
Google Scholar
PubMed Close
,
Silvana Bordin Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil

Search for other papers by Silvana Bordin in
Google Scholar
PubMed Close
, and
Gabriel Forato Anhê Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil

Search for other papers by Gabriel Forato Anhê in
Google Scholar
PubMed Close

was an indicative that mice allowed to breastfeed after delivery were able to exhibit a long-term increased in glucose-stimulated insulin secretion (GSIS) by pancreatic islets. Attempting to clarify this issue, we evaluated GSIS by pancreatic islets

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0020
Volume/Issue:
Volume 9: Issue 4
Open access
Mojca Jensterle Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Mojca Jensterle in
Google Scholar
PubMed Close
,
Nika Aleksandra Kravos Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Nika Aleksandra Kravos in
Google Scholar
PubMed Close
,
Simona Ferjan Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Simona Ferjan in
Google Scholar
PubMed Close
,
Katja Goricar University of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, Ljubljana, Slovenia

Search for other papers by Katja Goricar in
Google Scholar
PubMed Close
,
Vita Dolzan University of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, Ljubljana, Slovenia

Search for other papers by Vita Dolzan in
Google Scholar
PubMed Close
, and
Andrej Janez Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Search for other papers by Andrej Janez in
Google Scholar
PubMed Close

disturbances and menstrual irregularity ( 7 ). However, there is no clear answer for how long metformin should be prescribed in these subsets of patients, who would clearly benefit from long-term use of metformin in PCOS, and whether long-term treatment with

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0449
Volume/Issue:
Volume 9: Issue 1
Open access
Helle Døssing Department of Oto-rhino-laryngology and Neck Surgery, Odense University Hospital, Odense, Denmark
Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Helle Døssing in
Google Scholar
PubMed Close
,
Finn Noe Bennedbæk Department of Endocrinology and Metabolism, Herlev University Hospital, Herlev, Denmark

Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed Close
, and
Laszlo Hegedüs Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed Close

a way to reduce the side effects associated with treating the solid part of the nodule ( 16 ), LT has, in randomized studies, shown promising results ( 17 , 18 , 19 ). However, data on long-term efficacy after LT are limited and restricted to solid

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0236
Volume/Issue:
Volume 8: Issue 7
Open access
Charlotte Höybye Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Beverly M K Biller Neuroendocrine Unit, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed Close
,
Jean-Marc Ferran Qualiance ApS, Copenhagen, Denmark

Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed Close
,
Murray B Gordon Allegheny Neuroendocrinology Center, Division of Endocrinology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA

Search for other papers by Murray B Gordon in
Google Scholar
PubMed Close
,
Nicky Kelepouris US Medical Affairs-Rare Endocrine Disorders, Novo Nordisk, Inc, Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed Close
,
Navid Nedjatian Global Medical Affairs – Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Navid Nedjatian in
Google Scholar
PubMed Close
,
Anne H Olsen Epidemiology, Novo Nordisk A/S, Soborg, Denmark

Search for other papers by Anne H Olsen in
Google Scholar
PubMed Close
, and
Matthias M Weber Unit of Endocrinology, 1, Medical Department, University Hospital, Universitätsmedizin Mainz, der Johannes Gutenberg-Universität, Mainz, Germany

Search for other papers by Matthias M Weber in
Google Scholar
PubMed Close

metabolism, long-term GH treatment can lead to improved insulin levels and glycaemia due to concomitant body composition changes ( 10 , 11 , 12 ). Additionally, replacement with other hormones, especially pharmacological doses of glucocorticoids, might have

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-22-0267
Volume/Issue:
Volume 12: Issue 1
Open access
Cecilia Follin Department of Endocrinology, Skåne University Hospital, Lund, Sweden

Search for other papers by Cecilia Follin in
Google Scholar
PubMed Close
and
Sven Karlsson Department of Endocrinology, Skåne University Hospital, Lund, Sweden

Search for other papers by Sven Karlsson in
Google Scholar
PubMed Close

control symptoms. Pegvisomant is used in combination with SSA to gain increased efficacy ( 8 ). For the patients who are not cured with surgery, long-term treatment with SSA is the primary therapy used to achieve long-term remission and biochemical control

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0038
Volume/Issue:
Volume 5: Issue 4
Open access
Sherwin Criseno Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Helena Gleeson Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Helena Gleeson in
Google Scholar
PubMed Close
,
Andrew A Toogood Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Andrew A Toogood in
Google Scholar
PubMed Close
,
Neil Gittoes Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Neil Gittoes in
Google Scholar
PubMed Close
,
Anne Topping School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Anne Topping in
Google Scholar
PubMed Close
, and
Niki Karavitaki Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Niki Karavitaki in
Google Scholar
PubMed Close

longitudinal studies in adults over the age of 25 have shown that long-term treatment with GH does not normalise the metabolic profile and it even increases body mass index (BMI) ( 3 , 11 , 12 ). Currently, GH treatment in adults involves daily subcutaneous

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0533
Volume/Issue:
Volume 13: Issue 5
Open access